ArticleCancer immunology, immunotherapy : CII2024

Efficacy of durvalumab plus chemotherapy in advanced biliary duct cancer and biomarkers exploration.

Yunxin Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.